QNCX

QNCX

USD

Quince Therapeutics Inc. Common Stock

$1.600+0.040 (2.564%)

Preço em tempo real

Healthcare
Biotecnologia
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$1.560

Máximo

$1.620

Mínimo

$1.555

Volume

0.11M

Fundamentos da empresa

Capitalização de mercado

85.9M

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

0.27M

Bolsa de valores

NMS

Moeda

USD

Faixa de 52 semanas

Mínimo $0.72Atual $1.600Máximo $2.45

Notícias relacionadas

BusinessWire

Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting

Quince Therapeutics, Inc. (NASDAQ:QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today announced the poster presentation of

Ver mais
Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting
Analyst Upgrades

D. Boral Capital Maintains Buy on Quince Therapeutics, Maintains $4 Price Target

D. Boral Capital analyst Jason Kolbert maintains Quince Therapeutics with a Buy and maintains $4 price target.

Ver mais
D. Boral Capital Maintains Buy on Quince Therapeutics, Maintains $4 Price Target
BusinessWire

Quince Therapeutics Announces CPT: Pharmacometrics & Systems Pharmacology Publication of eDSP Population Pharmacokinetic Modeling Study

Quince Therapeutics, Inc.

Ver mais
Quince Therapeutics Announces CPT: Pharmacometrics & Systems Pharmacology Publication of eDSP Population Pharmacokinetic Modeling Study

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.